ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002

NCI Begins TAILORx Study.

May 26, 2006

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001